Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gajjar, A.
Right arrow Articles by Kun, L. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gajjar, A.
Right arrow Articles by Kun, L. E.

Journal of Clinical Oncology, Vol 15, 2792-2799, Copyright © 1997 by American Society of Clinical Oncology


ARTICLES

Low-grade astrocytoma: a decade of experience at St. Jude Children's Research Hospital

A Gajjar, RA Sanford, R Heideman, JJ Jenkins, A Walter, Y Li, JW Langston, M Muhlbauer, JM Boyett and LE Kun
St Jude Children's Research Hospital/Le Bonheur Children's Medical Center Brain Tumor Team, Memphis, TN 38105-2794, USA. amar.gajjar@stjude.org

PURPOSE: To evaluate the impact of primary tumor site, age at diagnosis, extent of resection, and histology on progression-free survival (PFS) in pediatric low-grade astrocytoma. PATIENTS AND METHODS: Medical, pathologic, and imaging information were reviewed for 142 children (ages 2 months to 19 years) with low-grade astrocytoma treated between January 1984 and July 1994. Gross total resection (GTR) was attempted for cerebellar and cerebral hemisphere tumors, with biopsy or less aggressive resection used predominantly for tumors in other sites. Surgery was followed by observation in 107 cases, radiation therapy in 31, and chemotherapy in four. RESULTS: The overall survival rate was 90% +/- 3% (SE) at 4 years. PFS was significantly better for patients with cerebellar and cerebral hemisphere tumors (n = 75) than those with tumors in all other sites (P = .0006). Within the former group, there was no significant difference in PFS for patients in whom GTR was achieved versus those with incomplete resections (4- year estimates, 89% and 77%, respectively). Histology (juvenile pilocytic v astrocytoma not otherwise specified [NOS]) was not related to PFS in an analysis that controlled for tumor site and patient age. Patients younger than 5 years at diagnosis had a significantly poorer PFS than older children, regardless of histology (P < .03) or tumor site (P < .002). Treatment for progressive/recurrent disease was effective in a majority of patients, but appeared more successful in patients with hemispheric than thalamic or hypothalamic tumors. CONCLUSION: The overall survival in this series of pediatric low-grade astrocytomas is excellent. Age at diagnosis and tumor location, but not histology, had a significant impact on PFS. Efforts to improve treatment outcome should focus on young patients (< 5 years) and on those with central midline tumors. The majority of patients with completely resected hemispheric tumors were monitored without further therapy, which supports attempted GTR of cerebral and cerebellar hemisphere low-grade astrocytoma.


This article has been cited by other articles:


Home page
J Child NeurolHome page
F. Nejat, M. El Khashab, and J. T. Rutka
Initial Management of Childhood Brain Tumors: Neurosurgical Considerations
J Child Neurol, October 1, 2008; 23(10): 1136 - 1148.
[Abstract] [PDF]


Home page
Neuro OncolHome page
K. K. Mishra, D. R. Puri, B. T. Missett, K. R. Lamborn, M. D. Prados, M. S. Berger, A. Banerjee, N. Gupta, W. M. Wara, and D. A. Haas-Kogan
The role of up-front radiation therapy for incompletely resected pediatric WHO grade II low-grade gliomas
Neuro-oncol, April 1, 2006; 8(2): 166 - 174.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K.-K. Wong, Y.-M. Chang, Y. T.M. Tsang, L. Perlaky, J. Su, A. Adesina, D. L. Armstrong, M. Bhattacharjee, R. Dauser, S. M. Blaney, et al.
Expression Analysis of Juvenile Pilocytic Astrocytomas by Oligonucleotide Microarray Reveals Two Potential Subgroups
Cancer Res., January 1, 2005; 65(1): 76 - 84.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
D. C. Bowers, L. Gargan, P. Kapur, J. S. Reisch, A. F. Mulne, K. N. Shapiro, R. D. Elterman, N. J. Winick, and L. R. Margraf
Study of the MIB-1 Labeling Index as a Predictor of Tumor Progression in Pilocytic Astrocytomas in Children and Adolescents
J. Clin. Oncol., August 1, 2003; 21(15): 2968 - 2973.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. Massimino, F. Spreafico, G. Cefalo, R. Riccardi, J. D. Tesoro-Tess, L. Gandola, D. Riva, A. Ruggiero, L. Valentini, E. Mazza, et al.
High Response Rate to Cisplatin/Etoposide Regimen in Childhood Low-Grade Glioma
J. Clin. Oncol., October 15, 2002; 20(20): 4209 - 4216.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
S M Yule, T A H Hide, M Cranney, E Simpson, and A Barrett
Low grade astrocytomas in the West of Scotland 1987-96: treatment, outcome, and cognitive functioning
Arch. Dis. Child., January 1, 2001; 84(1): 61 - 64.
[Abstract] [Full Text]


Home page
RadiologyHome page
A. J. Martin, W. A. Hall, H. Liu, C. H. Pozza, E. Michel, S. O. Casey, R. E. Maxwell, and C. L. Truwit
Brain Tumor Resection: Intraoperative Monitoring with High-Field-Strength MR Imaging-Initial Results
Radiology, April 1, 2000; 215(1): 221 - 228.
[Abstract] [Full Text]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 1997 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online